Neue Gentechnik und ‚Genome Editing‘

Proposal for necessary amendments of Annex I (NGT 1 plants)

TESTBIOTECH Background 19 – 11 – 2025 Summary The current compromise text to define criteria for Category 1 NGT status (Annex I) is based on a general misconception and is not in accordance with current scientific evidence. In short, the proposal does not consider that recombinant enzymatic mutagens, such as CRISPR/Cas, give rise to biological weiterlesen

Comment on the report “Compatibility of the EU proposal for a regulation on plants based on certain new genomic techniques with the Cartagena Protocol on Biosafety” Vöneky et al. (2025)

TESTBIOTECH Background 30 – 4 – 2025 Summary Whilst we agree with the finding of Vöneky et al. (2025) that the proposed EU legislation for plants obtained from new genetic engineering (new genomic techniques, NGTs) does not meet the obligations under the Cartagena Protocol in regard to notification, information and labeling, we would argue that weiterlesen